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Abstract
Objective—To review the evidence base
underlying recommended cessation coun-
selling for pregnant women who smoke, as
it applies to the steps identified in the
Agency for Healthcare Research and
Quality’s publication, Treating tobacco
use and dependence: a clinical practice
guideline.
Data sources—Secondary analysis of
literature reviews and meta-analyses.
Data synthesis—A brief cessation coun-
selling session of 5–15 minutes, when
delivered by a trained provider with the
provision of pregnancy specific, self help
materials, significantly increases rates of
cessation among pregnant smokers. This
low intensity intervention achieves a mod-
est but clinically significant eVect on
cessation rates, with an average risk ratio
of 1.7 (95% confidence interval 1.3 to 2.2).
There are five components of the
recommended method—“ask, advise,
assess, assist, and arrange”.
Conclusions—We recommend these evi-
dence based procedures be adopted by all
prenatal care providers. The use of this
evidence based intervention is feasible in
most oYce or clinic settings oVering pre-
natal care and can be implemented
without inhibiting other important as-
pects of prenatal care or disrupting
patient flow. If implemented widely, this
approach has the potential to achieve an
important reduction in a number of
adverse maternal, infant, and pregnancy
outcomes and to reduce associated, excess
health care costs.
(Tobacco Control 2000;9(Suppl III):iii80–iii84)
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Smoking cessation is one of the most important
actions a woman can take to improve the
outcome of her pregnancy. Despite the
acknowledged harm associated with tobacco
use during pregnancy for both mother and
infant,1 2 a large proportion of pregnant women
continues to smoke. Although some women
stop smoking once they learn they are pregnant,
the majority do not. Therefore, the
implementation of an eVective smoking
cessation intervention would have a significant
impact on the health of mothers and children.
Data sources
To develop consensus on a best practice inter-
vention for pregnant smokers, we reviewed the
evidence related to cessation counselling
during pregnancy in the published literature3–7
(table 1), including the evidence supporting
the Agency for Health Care Policy and
Research’s (AHCPR) clinical practice guide-
line, Smoking cessation,8 9 and its recent update,
Treating tobacco use and dependence: a clinical
practice guideline, by the Agency for Healthcare
Research and Quality (AHRQ, formerly
AHCPR).10 A panel of experts also considered
this literature and its implications for a best
practice intervention at the 1998 consensus
workshop on smoking cessation in pregnancy,
sponsored by the Robert Wood Johnson Foun-
dation’s Smoke-Free Families Program, the
Health Resources and Services Administra-
tion, and the Centers for Disease Control and
Prevention. Participants included representa-
tives from the American Cancer Society, the
National Cancer Institute, the National Heart,
Lung, and Blood Institute, the Association of
Maternal and Child Health Programs, the
Oklahoma Health Care Authority, the Partner-
ship for Prevention, and the Addressing
Tobacco in Managed Care initiative. The panel
considered three questions: (1) is pregnancy an
appropriate time for smoking cessation
eVorts?; (2) are interventions eVective?; and (3)
how can smoking cessation interventions be
introduced into health systems?
The panel concluded that pregnancy is an
appropriate time to achieve smoking cessation
and that successful interventions produce
clear, short term, and cost eVective benefits.
They also concluded that a brief cessation
counselling session can improve cessation rates
as compared to simple advice to quit, and that
more intensive counselling has not been docu-
mented to increase cessation rates among
pregnant smokers. Furthermore, they found
that almost all benefits of brief counselling
occur in light to moderate smokers.
Data synthesis
Based on these reviews of the evidence, we rec-
ommend a simple approach that has been
shown to increase cessation in prenatal
populations as compared to usual advice to
stop smoking. A brief cessation counselling
session of 5–15 minutes, when delivered by a
trained provider with the provision of
pregnancy specific, self help materials,
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significantly increases rates of cessation among
pregnant smokers.11 A previous meta-analysis
has found that this low intensity intervention
achieves a modest but clinically significant
eVect on cessation rates, with an average risk
ratio across the 16 studies (weighted by the
precision of each study’s risk ratio) of 1.7, and
a 95% confidence interval (95% CI) of 1.3 to
2.2.7 The average risk ratio of 1.7 suggests a
70% improvement in cessation, and the confi-
dence interval suggests that the outcome (ces-
sation) is at least 30% higher in the treated ver-
sus the untreated (control/comparison) groups
(table 112–26). It appears that this intervention is
at least as eVective with ethnic minority
women, notably African American women, as
with white, non-Hispanic women.12–14 It is less
eVective, however, with more addicted
smokers,12 13 15 and it is not clear what
additional interventions might be eVective with
these smokers.
Steps for cessation counselling during
pregnancy
We use the “ask, advise, assess, assist, and
arrange” steps as the basis for recommended
counselling for pregnant women. The “4 As”
(ask, advise, assist, and arrange) were
developed by Glynn and Manley and
recommended by the National Cancer
Institute for counselling smokers in clinical
practice.27 The AHCPR also adopted these
steps in its original smoking guideline.8 9 In the
revised guideline, a fifth step is also
recommended.10 Placed between the “advise”
and “assist” steps is the “assess” step in which
the willingness of smokers to make a quit
attempt is assessed. We suggest a minimum
time to perform each counselling step.
The AHRQ smoking cessation guideline
panel update used studies of general
populations to assess the impact of total
contact time for this type of cessation interven-
tion, using six time categories, ranging from
zero to > 300 minutes. The guideline panel
concluded that there was a dose response eVect
up through the category 31–90 minutes, but
that lengthier contact time did not improve
rates of cessation. Yet, because of the relatively
brief total contact time evaluated in the trials
with pregnant women assessed by the guideline
panel and the participants in the consensus
conference, we recommend total contact time
of 5–15 minutes plus self help materials.10 11 A
similar idea is expressed in the updated AHRQ
guideline recommendation as “interventions
that exceed minimal advice” —defined as < 3
minutes.10
Many pregnant women are reluctant to
disclose their smoking status at their first
prenatal visit. Deception rates as high as 23%
among Medicaid insured28 29 and 14% among
privately insured pregnant women30 have been
biochemically confirmed. Non-disclosure can
be reduced using the multiple choice question
shown above in either written or oral formats.
Tests of similar questions in both written and
oral formats have improved disclosure as com-
pared with the yes/no question typically used,
“Do you smoke?”.30 31
While biochemical methods to validate
smoking status are becoming more widely
available and aVordable—for example, cotinine
dipsticks for urine—the acceptability of such
testing is not known. Therefore, at present, we
do not recommend biochemical testing as part
of routine screening of all pregnant women for
smoking. Anonymous testing for a period of
Table 1 Settings, interventions, smoking cessation and risk ratios (95% confidence intervals) for 16 trials
Trial Setting Intervention
Treatment Control Risk ratio
n % n % (95% CI)
Sexton, Hebel 198416 Private + university
clinics (US)
One or more personal visits, monthly phone contact with
master’s level educator + biweekly mailed materials
389 31.9 392 6.9 4.6 (3.1 to 6.8)
Winsdor et al 198517 Public clinics (US) 10 minute session with bachelor’s level counsellor + materials
+ manual
102 13.7 104 1.9 7.1 (1.7 to 30.6)
ErshoV et al 198912 HMO (US) Brief counselling by health educator + 8 booklets mailed weekly 126 26.2 116 17.2 1.5 (0.9 to 2.5)
Burling et al 199118 Urban hospital clinic
(US)
Personal letter from chief of prenatal clinic + pamphlet 70 12.8 69 5.8 2.2 (0.7 to 6.8)
Hjalmarson et al 199119 Public clinics (Sweden) Self help manual distributed by obstetrician 444 12.6 209 8.6 1.5 (0.9 to 2.4)
Price et al 199120 Urban hospital clinic
(US)
Videotape + pamphlet + brief counselling with health
educator or booklet + counselling
123 4.9 70 1.4 3.4 (0.4 to 27.8)
O’Connor et al 199221 Group practice
(Canada)
20 minute counselling by public health nurse + manual +
phone contact
90 13.3 84 6.0 2.2 (0.8 to 6.1)
Peterson et al 199222 HMO (US) Mailed manual + audiotape 43 16.3 47 17.0 1.0 (0.4 to 2.4)
Windsor et al 199312 Public clinics (US) 15 minute counselling by educator + manual + clinic
reinforcement + mailed letter + “buddy” support methods +
quarterly newsletter
400 14.2 414 8.4 1.7 (1.1 to 2.5)
Secker-Walker et al
199423
University clinic (US) Counselling by trained counsellors at 1st 3 visits and at 36
weeks + booklet
136 10.3 176 8.5 1.2 (0.6 to 2.6)
Kendrick et al 199524 Public clinics (US) 1–5 minute counselling at multiple visits 233 8.2 284 9.2 0.9 (0.5 to 1.6)
Kendrick et al 199524 Public clinics + WIC
sites (US)
Brief counselling + material 307 7.2 546 5.1 1.4 (0.8 to 2.4)
Kendrick et al 199524 Public clinics + WIC
sites (US)
6 minute counselling in prenatal visits; 1–2 minute counselling
at WIC sites
348 3.7 347 4.3 0.9 (0.4 to 1.8)
Hartmann et al 199615 University clinic (US) Brief counselling by trained resident to set goals + material +
CO testing; goal setters contacted by volunteer
107 20.0 100 10.0 2.0 (1.0 to 4.0)
Walsh et al 199725 Public clinic (Australia) Brief advice by doctor + 14 minute videotape + 10 minute
counselling by midwife + manual
127 9.0 125 0.0 2.4 (1.0 to 5.6)
Gielen et al 199726 University clinic (US) Guide + 15 minute counselling by trained layperson + materials
for support person + clinic staV reinforcement and support
193 6.2 198 5.6 1.1 (0.5 to 2.5)
Summary risk ratio (random eVects model) = 1.7 (1.3 to 2.2)
Reprinted with permission from WB Saunders Co. Mullen PD. Maternal smoking during pregnancy and evidence- based intervention to promote cessation. In:
Spangler JG, ed. Primary care: clinics in oYce practice (tobacco use and cessation). Philadelphia: WB Saunders, 1999:26:577–89.
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time could be useful in establishing the true
prevalence of smoking in individual practices
or clinics.
For patients indicating at intake that they
have quit smoking since becoming pregnant,
recognition and encouragement may be helpful
in preventing relapse. This includes aYrming
their decision to quit, congratulating them on
their success in quitting, describing the health
benefits for them and their baby, and
encouraging them to remain abstinent.8 9 In
five randomised controlled trials, additional
enhancements to this approach were not found
to decrease the likelihood of relapse during
pregnancy.7 More research is needed to
identify and test innovative strategies that
might build on these simple techniques and
promote long term success of the spontaneous
quitter.
For women who identify themselves as
smokers at intake, clinicians should note this
on their charts. Each clinician or facility should
implement systems to identify and document
systematically the smoking status of pregnant
women.8–10 Findings from a meta-analysis of
nine randomised clinical trials indicated that
implementing a clinical system greatly
increases the rate at which clinicians intervene
with their patients who smoke.8 9
Step 2: ADVISE—1 minute
+ Provide clear, strong advice to quit with
personalised messages about the impact
of smoking and quitting on mother and
fetus.
The guideline recommends that clinicians
urge every smoker to quit in “a clear, strong
and personalised manner.”8–10 For pregnant
women, this should include discussions of the
multiple risks to mother and fetus and infant
from maternal smoking, and the benefits of
quitting for both. Advice should stress that
quitting smoking is one of the most important
actions a woman can take to improve the
outcome of her pregnancy, and that specific
harms for her and the baby can be reduced by
quitting. Women who stop smoking before
becoming pregnant or during the first four
months of pregnancy have the same risk of
having a low birth weight baby as women who
never smoked.32
It should also be noted that smoking
cessation has immediate health benefits for
women of all ages, whether or not they suVer
from smoking related diseases. Not only does
cessation before or during pregnancy reduce
the risk of maternal complications and adverse
pregnancy outcomes, it can also, if sustained,
benefit the woman and her health status long
term.
Step 3: ASSESS
+ Assess the willingness of the patient to
make a quit attempt within the next 30
days.
The revised AHRQ guideline recommends
that clinicians assess a patient’s willingness to
make a quit attempt before proceeding to the
“assist” and “arrange” steps.10 Specifically,
each pregnant smoker should be asked if she is
willing to make a quit attempt within the next
30 days. One approach to this assessment is:
“Quitting smoking is one of the most
important things you can do for your health
and your baby’s health. If we can give you some
help, are you willing to give it a try?” If she is
willing to make a quit attempt at this time, the
provider should move to step 4. For patients
who are unwilling to attempt cessation,
quitting advice, assessment and assistance can
be oVered in future visits in much the same
way they are with smokers who are ready to
quit. Most pregnancy tailored self help materi-
als contain special messages to build
motivation and confidence in support of a ces-
sation attempt.
The benefits of “cutting down” are diYcult
to measure or verify, so women who ask if cut-
ting down is helpful should be reinforced for
taking this step, but reminded that quitting
entirely brings the best results for their own
and their baby’s health.
Step 4: ASSIST—3 minutes +
+ Provide pregnancy specific, self help
smoking cessation materials.
+ Suggest and encourage the use of
problem solving methods and skills for
cessation.
+ Arrange social support in the smoker’s
environment.
+ Provide social support as part of the
treatment.
Step 1: ASK
+ Ask the patient about her smoking status
A. I have NEVER smoked, or I have
smoked less than 100 cigarettes in my
lifetime.
B. I stopped smoking BEFORE I found
out I was pregnant, and I am not
smoking now.
C. I stopped smoking AFTER I found
out I was pregnant, and I am not
smoking now.
D. I smoke some now, but I cut down on
the number of cigarettes I smoke
SINCE I found out I was pregnant.
E. I smoke regularly now, about the same
as BEFORE I found out I was
pregnant.
If patient responds to B or C, reinforce
her decision to quit, congratulate her
on success in quitting, and encourage
her to stay quit.
If patient responds D or E, she should
be classified as a smoker. Document
smoking status on her clinic chart, and
proceed to ADVISE, ASSESS, ASSIST
and ARRANGE.
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Analysis of the interventions tested with
pregnant women (table 1) indicate the
eVectiveness of providing pregnancy specific
patient education materials.17 Studies with
general samples of smokers also suggest that
teaching problem solving methods and
skills,8–10 arranging social support from family,
friends and co-workers,10 and receiving
support from the clinician are helpful,8–10
whereas contingency contracting, relaxation/
breathing, cigarette fading, and exercise/fitness
content are not.8–10
The following specific strategies are
recommended as part of providing assistance
to pregnant women who smoke:
Provide pregnancy specific, self help smoking cessa-
tion materials—An early study showed that
pregnancy related messages significantly
increased the likelihood of cessation.17 The
cessation rate of the group receiving the brief
counselling with a pregnancy tailored manual
was twice that of the group receiving the brief
counselling with a general cessation manual.17
Since then, all of the tested interventions have
used pregnancy specific information (table 1).
Materials should be relevant to pregnancy and
prenatal care as described above. Numerous
self help quitting guides tailored for pregnancy
have been tested and found eVective with preg-
nant smokers of varied demographic groups
(for example, ethnicity, income, education).
Information on pregnancy materials may be
found in the prenatal smoking cessation
combined health information database on the
web at http://chid.nih.gov.
Problem solving—Problem solving includes rec-
ognition of danger situations, relapse
prevention, coping and stress management,
and basic information about addiction and the
time course of withdrawal.8–10
Social support in the smoker’s environment—The
counsellor should prompt support seeking and
help the patient develop support solicitation
skills as approaches to gaining outside support
(for example, from family, friends, and
co-workers) for her decision to make a quit
attempt.10
Social support as part of treatment—Social
support from the counsellor means that the
counsellor is encouraging, communicates
caring and concern, and encourages the
patient to talk about the process of quitting.8 9
Addiction in the general population of
smokers is addressed in the guideline by strong
recommendations for the use of pharmaco-
therapies (for example, buproprion and
nicotine replacement therapy). Nicotine
replacement therapy as an adjunct to counsel-
ling has been shown to increase cessation
rates.8–10 More recently, buproprion, in
conjunction with nicotine replacement plus
counselling, has also shown a strong positive
eVect in a sample of non-depressed smokers.33
To date, no study has evaluated the eYcacy
and safety of these therapies during pregnancy.
Thus, the evidence, at this point, is not conclu-
sive about the ratio of potential harm to benefit
for use during pregnancy8–10 34–36 and supports
the need to consider pharmacotherapies only
after psychosocial intervention has failed.9 10
More research is needed on this topic before
specific recommendations can be made about
the use of pharmacotherapies during
pregnancy.37 Optimally, smokers can be treated
with these pharmacotherapies before
conception.10 38
Research findings indicate that the type of
behavioural counselling assistance described
above may not be suYcient for pregnant
women who are heavy smokers. While the
research is not clear on the best intensive
behavioural treatment for pregnant, heavy
smokers, referral to the types of counselling
recommended as more eVective in the AHRQ
Guideline should be considered.
Step 5: ARRANGE—1 minute +
+ Periodically assess smoking status and, if
she is a continuing smoker, encourage
cessation.
While quitting early in pregnancy is best,
smoking cessation brings benefits throughout
the pregnancy for the mother, fetus, and infant.
Smoking status should be monitored through-
out pregnancy providing opportunities to con-
gratulate and support success, reinforce steps
taken towards quitting, and advise those still
considering a cessation attempt.
Conclusions
In summary, data from randomised clinical tri-
als and from the meta-analyses used to update
the AHCPR clinical practice guideline on
smoking cessation show that a 5–15 minute
cessation counselling intervention delivered by
a trained provider, in conjunction with the pro-
vision of pregnancy specific self help materials,
can achieve a significant increase in cessation
during pregnancy.10 Thus, we recommend
these evidence based procedures be adopted by
all prenatal care providers.
We believe that the use of this intervention is
feasible in most oYce or clinic settings without
inhibiting other important aspects of prenatal
care or disrupting patient flow. If implemented
widely, this approach has the potential to
achieve an important reduction in a number of
adverse maternal, infant, and pregnancy
outcomes and to reduce associated, excess
health care costs.39–42
The authors wish to thank C Tracy Orleans for her valuable
review and comment on this paper. Attendees at the 1998 Con-
sensus Workshop on Smoking Cessation in Pregnancy: (in
alphabetical order): E Kathleen Adams, PhD, Department of
Health Policy and Management, Rollins School of Public
Health, Emory University; Trina M Anglin, MD, PhD,
Maternal and Child Health Bureau, Health Resources and
Services Administration (HRSA), Department of Health and
Human Services (DHHS); Dianne C Barker, Barker Bi-Coastal
Health Consultants, Calabassas, CA; Doris M Barnette ACSW,
Department of Health and Human Services, Health Resources
and Services Administration, Rockville, MD:Carolyn Aoyama,
CNM, MPH, Bureau of Primary Health Care, HRSA, DHHS;
Elaine Bratic Arkin, Consultant; Ashley CoYeld, Partnership
for Prevention; Carlo C DiClemente, PhD, Department of Psy-
chology, University of Maryland-Baltimore County; Karen M
Emmons, PhD, Cancer Epidemiology and Control,
Dana-Farber Cancer Institute; Roselyn Payne Epps, MD,
MPH, National Cancer Institute, National Institutes of Health
(NIH), DHHS; Daniel H ErshoV, DrPH, Southern California
Kaiser-Permanente; Robert L Goldenberg, MD, Smoke-Free
Families National Program OYce, Department of Obstetrics
and Gynecology, University of Alabama, Birmingham, AL;
Thomas J Glynn, PhD, American Cancer Society; Robin Hill,
PhD, National Heart, Lung, and Blood Institute, NIH, DHHS;
Recommended cessation counselling for pregnant smokers iii83
www.tobaccocontrol.com
Ruth R Karimi, Consultant; Lorraine V Klerman, DrPH,
Smoke-Free Families Program, University of Alabama at
Birmingham; Nancy Maddox, MPH, Association of Maternal
and Child Health Programs; Helen E McIlvain, PhD,
Department of Family Practice, University of Nebraska
Medical Center; Cathy L Melvin, PhD, MPH, Program
Services and Development Branch, Division of Reproductive
Health, CDC, Atlanta, GA; Patricia Dolan-Mullen, DrPH,
Center for Health Promotion Research and Development,
School of Public Health, University of Texas Health Sciences
Center, Houston, TX; C Tracy Orleans, PhD, Research and
Evaluation Unit, Robert Wood Johnson Foundation, Princeton,
NJ; Rebecca Pasternik-Ikard, JD, MS, RN, Managed Care
Organization Operations, Oklahoma Health Care Authority
(OHCA); Susan L Prows, PhD, MPH, Department of Public
Health, Oregon State University; Jordan Richland, MPA, Part-
nership for Prevention; Abby C Rosenthal, MPH, National
Technical Assistance OYce, Addressing Tobacco in Managed
Care; Laura J Solomon, PhD, Department of Psychology, Uni-
versity of Vermont; Gary Stuart, MEd, National Center for
Chronic Disease Prevention and Health Promotion, Centers for
Disease Control and Prevention, DHHS; Jana Webb, RN,
Medical Professional Services, OHCA; H Pennington
Whiteside, MSPH, Smoke-Free Families National Program
OYce, Department of Obstetrics and Gynecology, University of
Alabama, Birmingham, AL; Richard A Windsor, PhD, MPH,
Smoke-Free Families National Program OYce, University of
Alabama, Birmingham, AL.
1 DiFranza JR, Lew RA. EVect of maternal cigarette smoking
on pregnancy complications and sudden infant death syn-
drome. J Fam Pract 1995;40:385–94.
2 Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML.
EVects of smoking during pregnancy. Five meta-analyses.
Am J Prev Med 1999;16:208–15.
3 Windsor RA, Orleans CT. Guidelines and methodological
standards for smoking cessation intervention research
among pregnant women: improving the science and art.
Health Educ Q 1986;13:131–61.
4 Dolan-Mullen P, Ramirez G, GroV JY. Obstetrics: a
meta-analysis of randomized trials of prenatal smoking
cessation interventions. Am J Obstet Gynecol 1994;
171:1328–34.
5 Windsor RA, Boyd NR, Orleans CT. A meta-evaluation of
smoking cessation intervention research among pregnant
women: improving the science and art. Health Educ Res
1998;13:419–38.
6 Dolan-Mullen P. Essential elements of state-of-the-art
smoking cessation interventions for pregnant smokers
based on available research evidence, meta-analysis and
AHCPR smoking cessation clinical practice guideline. In
Barker DC, Barnette DM, Goldenberg RL, et al.
Summary: consensus on smoking cessation in pregnancy,
Rockville, Maryland, 9–10 April 1998. http://
www.smokefreefamilies.uab.edu/web-ccs.doc
7 Mullen PD. Maternal smoking during pregnancy and
evidence-based intervention to promote cessation. In:
Spangler JG, ed. Primary care: clinics in oYce practice
(tobacco use and cessation). Philadelphia: WB Saunders,
1999;26:577–89.
8 Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation.
Clinical Practice Guideline No 18. Rockville, Maryland:
US Department of Health and Human Services, Public
Health Service, Agency for Health Care Policy and
Research, April 1996. (AHCPR Publication No 96–
0692.); <http://text.nlm.nih.gov>.
9 Agency for Health Care Policy and Research. AHCPR
smoking cessation clinical practice guideline. JAMA 1996;
275:1270–80.
10 Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and
dependence: a clinical practice guideline. Rockville, Maryland:
US Department of Health and Human Services. A Public
Health Service report. May 2000.
11 Consensus Workshop on Smoking Cessation during Preg-
nancy. Sponsored by the Robert Wood Johnson Founda-
tion and the Smoke-Free Families Program in collabora-
tion with the Health Resources and Services
Administration and the Centers for Disease Control and
Prevention. Rockville, Maryland, 9–10 April 1998.
12 ErshoV DH, Mullen PD, Quinn VP. A randomized trial of
serialized self-help smoking cessation program for pregnant
women in an HMO. Am J Public Health 1989;79:182–7.
13 Windsor RA, Lowe JB, Perkins LL, et al. Health education
methods for pregnant smokers: its behavioral impact and
cost benefit. Am J Public Health 1993;83:201–6.
14 Woodby LL, Windsor RA, Snyder SW, et al. Predictors of
smoking cessation during pregnancy. Addiction 1999;
94:283–92.
15 Hartmann KE, Thorp JM, Pahel-Short L, et al. A
randomized controlled trial of smoking cessation interven-
tion in pregnancy in an academic clinic. Obstet Gynecol
1996;87:621–6.
16 Sexton M, Hebel JR. A clinical trial of change in maternal
smoking and its eVects on birth weight. JAMA 1984;
251:911–5.
17 Windsor RA, Cutter G, Morris J, et al. EVectiveness of
smoking cessation methods for smokers in public health
maternity clinics: a randomized trial. Am J Public Health
1985;75:1389–92.
18 Burling TA, Bigelow GE, Robinson JC, et al. Smoking dur-
ing pregnancy: reduction via objective assessment and
directive advice. Behavior Therapy 1991;22:31–40.
19 Hjalmarson AIM, Hahn L, Svanberg B. Stopping smoking
in pregnancy: eVect of a self-help manual in controlled
trial. Br J Obstet Gynaecol 1991;98:260–4.
20 Price JH, Desmond SM, Roberts SM, et al. Comparison of
three antismoking interventions among pregnant women
in an urban setting: a randomized trial. Psychological
Reports 1991;68:595–604.
21 O’Connor AM, Davies BL, Dulberg CS, et al. EVectiveness
of a pregnancy smoking cessation program. J Obstet Gyne-
col Neonatal Nurs 1992;21:385–92.
22 Petersen L, Handel J, Kotch SM, et al. Smoking reduction
during pregnancy by a program of self-help and clinical
support. Obstet Gynecol 1992;79:924–30.
23 Secker-Walker RH, Solomon LJ, Flynn BS, et al. Individual-
ized smoking cessation counseling during prenatal and early
postnatal care. Am J Obstet Gynecol 1994;171:1347–55.
24 Kendrick JS, Zahniser SC, Miller N, et al. Integrating smok-
ing cessation into routine public prenatal care: the
smoking cessation in pregnancy project. Am J Public
Health 1995;85:217–22.
25 Walsh RA, Redman S, Brinsmead MW, et al. A smoking ces-
sation program at a public antenatal clinic. Am J Public
Health 1997;87:1201–4.
26 Gielen AC, Windsor R, Faden RR, et al. Smoking cessation
among pregnant women in an urban clinic: evaluation of a
community health worker intervention. Health Education
Research: Theory and Practice 1997;12:247–54.
27 Glynn TJ, Manley MW. How to help your patients stop smok-
ing: a National Cancer Institute manual for physicians, Wash-
ington, DC: Smoking and Tobacco Control Program,
Division of Cancer Prevention, National Cancer Institute,
US Dept of Health and Human Services, November 1990.
(NIH publication 90–3064.)
28 Windsor RA. Health care delivery issues and systems. Pres-
entation at consensus workshop on smoking cessation in
pregnancy, Health Resources and Services Administra-
tion, Rockville, Maryland, 9–10 April 1998.
29 Windsor RA, Woodby LA, Miller T, et al. EVectiveness of
AHCPR practice recommendations and patient education
methods for pregnant smokers in Medicaid maternity
care. Am J Obstet Gynecol 2000;182:68–75.
30 Mullen PD, Carbonari JP, Tabak ER, et al. Improving the
disclosure of smoking by pregnant women. Am J Obstet
Gynecol 1991;165:409–13.
31 Kharazi M, Epstein D, Hopkins B, et al. Evaluation of four
maternal smoking questions. Public Health Reports 1999;
114:60–9.
32 US Department of Health and Human Services. The health
benefits of smoking cessation. A report of the Surgeon General.
Rockville, Maryland: US Department of Health and
Human Services, Public Health Service, Centers for
Disease Control, Center for Chronic Disease Prevention
and Health Promotion, OYce on Smoking and Health,
1990. (DHHS Publication No. (CDC) 90–8416.)
33 Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial
of sustained release buproprion, a nicotine patch, or both
for smoking cessation. N Engl J Med 1999;340:685–91.
34 Wisborg K, Jespersen L, Henriksen TB, et al. Nicotine
patches to pregnant smokers—a randomized study. Presented
at the First International Conference of the Society for
Research on Nicotine and Tobacco, Copenhagen, Den-
mark, August 23, 1998.
35 Oncken CA, Hatsukami DK, Lupo VR, et al. EVects of
short-term use of nicotine gum in pregnant smokers. Clin
Pharmacol Ther 1996;59:654–61.
36 Benowitz NL, Pinney J. Nicotine preparations in smoking.
In: Korting HC, Schafer-Korting M, eds. The benefit/risk
ratio. Boca Raton: CRC Press, 1999:307–18.
37 Workshop on the Use of Pharmacotherapies for Smoking
Cessation in Pregnancy. Sponsors: National Institute for
Child Health and Human Development and the Smoke-
Free Families Program. Rockville, Maryland, 19 May
1999.
38 Public Health Service Expert Panel on the Content of Pre-
natal Care. Caring for our future: the content of prenatal care.
Report of the Public Health Service Expert Panel on the
content of prenatal care. Washington, DC: Public Health
Service/US Department of Health and Human Services,
1989.
39 Windsor RA, Warner KE, Cutter GR. A cost-eVectiveness
analysis of self-help methods for pregnant women. Public
Health Rep 1988;103:83–8.
40 Marks JS, Koplan JP, Hogue CJ, et al. A cost-benefit analy-
sis of smoking cessation for pregnant women. Am J Prev
Med 1990;6:282–9.
41 ErshoV DH, Quinn VP, Mullen PD, et al. Pregnancy and
medical cost outcomes of a self-help prenatal smoking ces-
sation program in an HMO. Public Health Rep 1990;
105:340–7.
42 Melvin CL, Adams EK, Miller V. Costs of smoking during
pregnancy: development of the maternal and child health
smoking attributable mortality, morbidity and economic
costs (MCHSAMMEC) software. Tobacco Control 2000;
9(suppl III):iii12–15.
iii84 Melvin, Dolan-Mullen, Windsor, et al
www.tobaccocontrol.com
